Citations

Showing 10 of 108104 citations.

Decompression With or Without Fusion for Adjacent Segment Disease Without Instability
Wanderman, Nathan , Geletta, Mattew, Sharma, Rishi , Sebastian, Arjun S. , Kaye, David , Sebastian, Arjun

Mayo Clinic

Clinical Spine Surgery: A Spine Publication | November 20, 2018 | Volume: 32 | Issue: 5 | Pages: 179-181

10.1097/bsd.0000000000000750 | PMID 30475242 Get It

The Nepean Dyspepsia Index is a valid instrument for measuring quality-of-life in functional dyspepsia
Jones, Michael P., Sato, Yuri , Talley, Nicholas J., Jones, Michael , Sato, Yuri A, Jones, Michael P , Jones, Michael P.

Mayo Clinic

European Journal of Gastroenterology & Hepatology | November 20, 2018 | Volume: 31 | Issue: 3 | Pages: 329-333

10.1097/meg.0000000000001314 | PMID 30461521 Get It

Background The Nepean Dyspepsia Index (NDI) has been in widespread use since its publication in 1999 and the addition of a short form in 2001. The NDI was one of the first disease-specific quality-of-life instruments created for functional dyspepsia (FD). However, its psychometric properties have never been validated in an independent sample. Aim This study aimed to evaluate the validity and reliability of the NDI in an a-priori driven approach in an independent population. Patients and methods In 289 individuals who fulfilled the Rome criteria for FD enrolled in a randomized placebo-controlled trial (FD treatment trial), we examined construct validity, convergent validity, and internal consistency. Results Construct validity was supported in its 25-item unweighted and weighted forms as well as the 10-item short form. All items in the 25-item form yielded considerable (>0.5) standardized loadings on their respective latent variables and all reached statistical significance ( P <0.0001), supporting their relationships with the hypothesized domains. Convergent validity was strongly supported, with every domain being correlated with multiple external instruments; the majority of correlations were in the range 0.3–0.5 (in absolute values). The items comprising each domain showed good internal consistency, with the lowest value of Chronbach α at 0.80. Scores based on the short form (10-item) version of the NDI correlated strongly with the full 25-item form (tension ρ =0.88, interference ρ =0.94, eat/drink ρ =0.95, knowledge ρ =0.84 and work/study ρ =0.97; all P <0.0001). Conclusion The NDI is a valid instrument that can be used to measure the disease-specific impact of FD on quality of life.
Evaluating Susceptibility to Pancreatic Cancer: ASCO Provisional Clinical Opinion
McKernin, Shannon, Moravek, Cassadie, Nagarajan, Arun , Petersen, Gloria M. , Simeone, Diane M. , Yurgelun, Matthew B. , Khorana, Alok A. , Stoffel, Elena M. , Brand, Randall E. , Canto, Marcia Irene , Goggins, Michael

Mayo Clinic

Journal of Clinical Oncology | November 20, 2018 | Volume: 37 | Issue: 2 | Pages: 153-164

10.1200/jco.18.01489 | PMID 30457921 Get It

Purpose An ASCO provisional clinical opinion (PCO) offers timely clinical direction to ASCO’s membership and other health care providers. This PCO addresses identification and management of patients and family members with possible predisposition to pancreatic adenocarcinoma. Methods ASCO convened an Expert Panel and conducted a systematic review of the literature published from January 1998 to June 2018. Results of the databases searched were supplemented with hand searching of the bibliographies of systematic reviews and selected seminal articles and contributions from Expert Panel members’ curated files. Provisional Clinical Opinion All patients diagnosed with pancreatic adenocarcinoma should undergo assessment of risk for hereditary syndromes known to be associated with an increased risk for pancreatic adenocarcinoma. Assessment of risk should include a comprehensive review of family history of cancer. Individuals with a family history of pancreatic cancer affecting two first-degree relatives meet criteria for familial pancreatic cancer (FPC). Individuals (cancer affected or unaffected) with a family history of pancreatic cancer meeting criteria for FPC, those with three or more diagnoses of pancreatic cancer in same side of the family, and individuals meeting criteria for other genetic syndromes associated with increased risk for pancreatic cancer have an increased risk for pancreatic cancer and are candidates for genetic testing. Germline genetic testing for cancer susceptibility may be discussed with individuals diagnosed with pancreatic cancer, even if family history is unremarkable. Benefits and limitations of pancreatic cancer screening should be discussed with individuals whose family history meets criteria for FPC and/or genetic susceptibility to pancreatic cancer. Additional information is available at www.asco.org/gastrointestinal-cancer-guidelines .
Role of Stress and Psychosocial Determinants on Women's Cardiovascular Risk and Disease Development
Medina‐Inojosa, José R. , Vinnakota, Shravya , García, Mariana, Calle, Maria Arciniegas, Bhagra, Anjali , Arciniegas Calle, Maria, Medina-Inojosa, José R , Mulvagh, Sharon L. , López-Jiménez, Francisco

Mayo Clinic

Journal of Women's Health | November 20, 2018 | Volume: 28 | Issue: 4 | Pages: 483-489

10.1089/jwh.2018.7035 | PMID 30457922 Get It

The notion that cardiovascular disease (CVD) primarily occurs in men is slowly disappearing. More women than men die of CVD every year, and when women survive, the burden and consequences are worse than in men. Markers of stress and other psychosocial factors have been associated with poor outcomes. Multiple studies have demonstrated sex-based differences in the vascular and endothelial responses to mental stress. Psychosocial stressors were also found to be independent risk factors for the development and progression of CVD. This review arises from accumulating evidence suggesting that psychological well-being may improve cardiac-related outcomes, independent of cardiac risk factors. Despite the fact that positive physician-patient engagement is likely to play a critical role in promoting positive psychological traits and healthy behaviors, current physician awareness and advocacy are rather suboptimal, despite active awareness campaigns such as the American Heart Association's Go Red for Women ® . There is a need to further study the role and management of stress as a CVD risk factor, especially in women, who are disproportionately affected.
A Comparison of Various Cervical Muscle Strength Testing Methods Using a Handheld Dynamometer
Hansen, Kelsey A., Hastreiter, Matthew J., Kuhn, Taylor, Peichel, Molly L., Hollman, John H. , Kuhn, Taylor N, Hollman, John , Krause, David A.

Mayo Clinic

Sports Health: A Multidisciplinary Approach | November 20, 2018 | Volume: 11 | Issue: 1 | Pages: 59-63

10.1177/1941738118812767 | PMID 30457924 Get It

Background: Cervical muscle strength, proposed as a modifiable risk factor in concussions, can be assessed using various methods. The purpose of this study was to compare the reliability and force outputs of 3 methods that use handheld dynamometry (HHD) for assessing cervical muscle strength. Hypothesis: All 3 testing methods are reliable, and force outputs are significantly different between methods. Study Design: Repeated-measures reliability. Level of Evidence: Level 5. Methods: The study used a convenience sample of 30 participants. HHD “make tests” for cervical extension, flexion, and right and left side bending were performed using lying push tests, sitting push tests, and sitting pull tests. A sole examiner performed all tests. Two testing sessions were conducted 1 week apart. Analysis included intraclass correlation coefficients (ICCs), repeated-measures analyses of variance (α = 0.05) with post hoc Bonferroni tests, and minimal detectable change (MDC) calculations. Results: All testing methods were reliable; the lying push test had the greatest point estimate values (ICC, 0.89-0.95). Significant differences in force were found between the 3 testing methods. The MDC was most sensitive for the lying push method. Conclusion: Of the 3 cervical muscle testing methods investigated, the lying position with a push test had the largest ICC according to the point estimate and the most sensitive MDC. Force values between the 3 methods were significantly different, which suggests that consistent testing methods should be used. Clinical Relevance: Results from this study support the clinical use of an HHD “make test” in a lying position for assessing cervical muscle strength. The test is reliable and more sensitive to change compared with tests in a seated position.
Dosimetry for the study of medical radiation workers with a focus on the mean absorbed dose to the lung, brain and other organs
Yoder, R. Craig , Dauer, Lawrence T. , Balter, Stephen , Grogan, Helen A. , Passmore, Christopher, Rothenberg, L. N., Vetter, Richard J., Boice, John D. , Mumma, Michael T.

Mayo Clinic

International Journal of Radiation Biology | November 20, 2018 | Volume: 98 | Issue: 4 | Pages: 619-630

10.1080/09553002.2018.1549756 | PMID 30451566 Get It

The phosphorylation status of PIP5K1C at serine 448 can be predictive for invasive ductal carcinoma of the breast
Durand, Nisha , Borgés, Sahra, Hall, Tavia, Bastea, Ligia I. , Döppler, Heike, Edenfield, Brandy , Thompson, E. Aubrey , Geiger, Xochiquetzal J., Störz, Peter , Bastea, Ligia, Edenfield, Brandy H, Geiger, Xochiquetzal, Bastea, Ligia

Mayo Clinic

Oncotarget | November 20, 2018 | Volume: 9 | Issue: 91 | Pages: 36358-36370

10.18632/oncotarget.26357 | PMID 30555634 Get It

The association between renal function and neurological diseases in type 2 diabetes: a multicenter nationwide cross-sectional study
Kaewput, Wisit , Thongprayoon, Charat , Mao, Michael A. , Cheungpasitporn, Wisit , Mao, Michael A , Cheungpasitporn, Wisit , Kaewput, Wisit , Thongprayoon, Charat , Rangsin, Ram , Satirapoj, Bancha

Mayo Clinic

Hospital Practice | November 20, 2018 | Volume: 47 | Issue: 1 | Pages: 46-52

10.1080/21548331.2019.1549916 | PMID 30445880 Get It

Squamous cell carcinoma of the rectum: Practice trends and patient survival
Dutta, Sunil W. , Alonso, Clayton E., Waddle, Mark R. , Khandelwal, Shiv R. , Trifiletti, Daniel M. , Trifiletti, Daniel M , Janowski, Einsley‐Marie

Mayo Clinic

Cancer Medicine | November 20, 2018 | Volume: 7 | Issue: 12 | Pages: 6093-6103

10.1002/cam4.1893 | PMID 30457223 Get It

AbstractPurposeLeverage the National Cancer Database (NCDB) to evaluate trends in management of nonmetastatic squamous cell cancer (SCC) of the rectum and their effect on survival for this uncommon tumor.Methods and MaterialsRetrospective data was obtained from the NCDB for patients diagnosed with SCC of the rectum between 2004 and 2014, including cT1‐4, cN0‐2, cM0 tumors (cohort A, n = 2296). A subgroup analysis was performed on locally advanced tumors (cT1‐T2, N+ or cT3, N any, subcohort B, n = 883), treated with chemoradiation (n = 706) or trimodality therapy (n = 177) including chemotherapy, radiation, and surgery. Pathological complete response rate following neoadjuvant therapy was obtained. Univariate and multivariate logistic regression analyses were performed to generate hazard ratios (HR) investigating factors associated with overall survival. Kaplan‐Meier (K‐M) method was used to estimate overall surviving proportion at 5 and 10 years.ResultsThe K‐M estimated 5 and 10 year overall survival for stage I disease was 71.3% and 57.8%, respectively; stage II disease was 57.0% and 38.9%, respectively; stage III disease was 57.8% and 41.5%, respectively. On multivariate analysis, higher cT category (P < 0.001) resulted in worse survival. For locally advanced tumors (subcohort B), there was no significant difference in survival between chemoradiation alone compared to trimodality therapy (P = 0.909 on multivariate analysis).ConclusionsMost providers manage locally advanced SCC of the rectum similar to anal cancer, which results in equivalent overall survival and spares patients from the additional morbidity associated with surgical resection.
Non‐Hodgkin lymphoma presenting as acute pancreatitis: A rare occurrence
Pitlick, Mitchell M. , Abeykoon, Jithma P. , Dao, Linda N. , Thompson, Carrie A.

Mayo Clinic

Clinical Case Reports | November 20, 2018 | Volume: 7 | Issue: 1 | Pages: 107-109

10.1002/ccr3.1885 | PMID 30656020 Get It

Key Clinical MessageLymphoma often presents with extranodal manifestations. However, pancreatic involvement resulting in pancreatitis is rare. CD20‐negative variants of diffuse large B‐cell lymphoma are also rare and are more likely to present with extranodal involvement. Lymphoma should be considered in patients presenting with pancreatitis without traditional risk factors.